{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:04:42Z","timestamp":1793412282674,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jaad.2025.11.043","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:14:44Z","timestamp":1763640884000},"page":"914-923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Management of cutaneous squamous cell carcinoma: A literature review and update"],"prefix":"10.1016","volume":"94","author":[{"given":"Megan H.","family":"Trager","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Breneman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"LeWitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Cahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murad","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Billingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishwer S.","family":"Nehal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Vidimos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faramarz H.","family":"Samie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2025.11.043_bib1","first-page":"110","article-title":"Non-melanoma skin cancer: statistical associations between clinical parameters","volume":"48","author":"Ciuciulete","year":"2022","journal-title":"Curr Health Sci J"},{"key":"10.1016\/j.jaad.2025.11.043_bib2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/ajd.12282","article-title":"Incidence and prevalence of non-melanoma skin cancer in Australia: a systematic review","volume":"56","author":"Perera","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.det.2022.07.004","article-title":"Squamous cell carcinoma: an update in staging, management, and postoperative surveillance strategies","volume":"41","author":"Guzman","year":"2023","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2025.11.043_bib4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/TP.0b013e3181ec7228","article-title":"Aggressive behavior of nonmelanotic skin cancers in solid organ transplant recipients","volume":"90","author":"Lott","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2025.11.043_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jaad.2015.04.037","article-title":"Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy","volume":"73","author":"Manyam","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib6","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jaad.2022.08.050","article-title":"Immune status does not independently influence cutaneous squamous cell carcinoma metastasis and death when stratified by tumor stage: a dual-center retrospective cohort analysis of primary N0 disease","volume":"87","author":"O'Connor","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-6143.2012.04292.x","article-title":"A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population","volume":"13","author":"Harwood","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jaad.2025.11.043_bib8","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.transproceed.2004.12.062","article-title":"Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience","volume":"37","author":"Buell","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jaad.2025.11.043_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.canep.2010.07.002","article-title":"Incidence of cancer in kidney-transplant recipients: a long-term cohort study in a single center","volume":"35","author":"Wisgerhof","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.jaad.2025.11.043_bib10","series-title":"NCCN Guidelines Version 2.2025 Squamous Cell Skin Cancer National Comprehensive Cancer Network","author":"Network","year":"2025"},{"key":"10.1016\/j.jaad.2025.11.043_bib11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1200\/JCO.2012.48.5326","article-title":"Evaluation of American Joint Committee on Cancer, International Union against Cancer, and Brigham and Women's hospital tumor staging for cutaneous squamous cell carcinoma","volume":"32","author":"Karia","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2025.11.043_bib12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamadermatol.2019.0032","article-title":"Performance of the American Joint Committee on cancer staging manual, 8th edition vs the Brigham and women's hospital tumor classification system for cutaneous squamous cell carcinoma","volume":"155","author":"Ruiz","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib13","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bjd.20909","article-title":"Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data","volume":"186","author":"Venables","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib14","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/DSS.0000000000001146","article-title":"Detection of high-risk histologic features and tumor upstaging of nonmelanoma skin cancers on debulk analysis: a quantitative systematic review","volume":"43","author":"Singh","year":"2017","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2025.11.043_bib15","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jaad.2024.11.082","article-title":"Prevalence of poor outcomes in cutaneous squamous cell carcinoma by AJCC and BWH tumor stages: a systematic review and meta-analysis","volume":"92","author":"Zakhem","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib16","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaad.2025.02.052","article-title":"Identifying the impact of minor risk factors in Brigham and women's hospital stage T1 cutaneous squamous cell carcinomas on risk of poor outcomes: a retrospective cohort study","volume":"92","author":"Shahwan","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/DSS.0000000000004187","article-title":"Lymphovascular invasion in cutaneous squamous cell carcinoma","volume":"50","author":"Ryan","year":"2024","journal-title":"Dermatol Surg"},{"issue":"1","key":"10.1016\/j.jaad.2025.11.043_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaad.2025.02.076","article-title":"riSCC: a personalized risk model for the development of poor outcomes in cutaneous squamous cell carcinoma","volume":"93","author":"Jambusaria-Pahlajani","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jamadermatol.2021.4989","article-title":"Radiologic imaging for high-stage cutaneous squamous cell carcinomas","volume":"158","author":"Ruiz","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib20","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaad.2023.01.012","article-title":"Perioperative imaging for high-stage cutaneous squamous cell carcinoma helps guide management in nearly a third of cases: a single-institution retrospective cohort","volume":"88","author":"Gibson","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/DSS.0000000000004191","article-title":"Use of imaging in cutaneous squamous cell carcinoma to detect high-risk tumor features, nodal metastasis, and distant metastasis: a systematic review","volume":"50","author":"Libson","year":"2024","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2025.11.043_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2016.08.051","article-title":"The positive impact of radiologic imaging on high-stage cutaneous squamous cell carcinoma management","volume":"76","author":"Ruiz","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib23","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jaad.2025.04.028","article-title":"Radiologic imaging aids management of high-risk cutaneous squamous cell carcinoma: a retrospective cohort study","volume":"93","author":"Wei","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib24","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/DSS.0000000000000526","article-title":"Clinical and pathologic factors predictive of positive radiologic findings in high-risk cutaneous squamous cell carcinoma","volume":"41","author":"Marrazzo","year":"2015","journal-title":"Dermatol Surg"},{"issue":"6","key":"10.1016\/j.jaad.2025.11.043_bib25","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/jamainternmed.2025.0505","article-title":"Projected lifetime cancer risks from current computed tomography imaging","volume":"185","author":"Smith-Bindman","year":"2025","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaad.2025.11.043_bib26","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1007\/s00259-022-05843-4","article-title":"Comparison of CT, MRI, and F-18 FDG PET\/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis","volume":"49","author":"Burian","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jaad.2025.11.043_bib27","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1200\/jco.2010.28.15_suppl.8079","article-title":"Comparison of contrast-enhanced CT, PET\/CT, PET, and low-dose non-contrast enhanced CT imaging of diffuse large B-cell (DLBCL), follicular (FL), small lymphocytic\/CLL (CLL\/SLL), and marginal zone lymphomas (MZL)","volume":"28","author":"Chong","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2025.11.043_bib28","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jaad.2018.09.006","article-title":"Nodal staging of high-risk cutaneous squamous cell carcinoma","volume":"81","author":"Fox","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib29","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaad.2017.04.1108","article-title":"Efficacy of curettage alone for invasive cutaneous squamous cell carcinoma: a retrospective cohort study","volume":"77","author":"Yakish","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2025.11.043_bib30","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/DSS.0000000000004728","article-title":"Recurrence rates of keratinocyte carcinoma treated with curettage alone: a retrospective cohort and interview study","volume":"51","author":"Jensen","year":"2025","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2025.11.043_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00006534-198707000-00007","article-title":"Shave excision of superficial solar skin lesions","volume":"80","author":"Emmett","year":"1987","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2025.11.043_bib32","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jaad.2012.06.009","volume":"67","author":"Connolly","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib33","first-page":"279","article-title":"Squamous cell carcinomas of the skin of the pinna","volume":"18","author":"Shiffman","year":"1975","journal-title":"Can J Surg"},{"key":"10.1016\/j.jaad.2025.11.043_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jaad.2021.07.067","article-title":"Efficacy of nonexcisional treatment modalities for superficially invasive and in situ squamous cell carcinoma: a systematic review and meta-analysis","volume":"87","author":"Stewart","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib35","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/jid.2012.403","article-title":"Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma","volume":"133","author":"Chren","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0190-9622(92)70178-I","article-title":"Surgical margins for excision of primary cutaneous squamous cell carcinoma","volume":"27","author":"Brodland","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib37","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3441","article-title":"Incomplete excision of cutaneous squamous cell carcinoma; systematic review of the literature","volume":"100","author":"Genders","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2025.11.043_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f6153","article-title":"Interventions for non-metastatic squamous cell carcinoma of the skin: systematic review and pooled analysis of observational studies","volume":"347","author":"Lansbury","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jaad.2025.11.043_bib39","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/DSS.0000000000002965","article-title":"A systematic review of primary, adjuvant, and salvage radiation therapy for cutaneous squamous cell carcinoma","volume":"47","author":"Krausz","year":"2021","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2025.11.043_bib40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaad.2018.04.033","article-title":"Appropriate use criteria in dermatopathology: initial recommendations from the American Society of Dermatopathology","volume":"80","author":"Vidal","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2025.11.043_bib41","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jamadermatol.2024.6214","article-title":"Mohs surgery vs wide local excision in primary high-stage cutaneous squamous cell carcinoma","volume":"161","author":"Wang","year":"2025","journal-title":"JAMA Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2025.11.043_bib42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaad.2025.04.010","article-title":"A multicenter validation study of Mohs micrographic surgery versus wide local excision in primary high-stage cutaneous squamous cell carcinoma","volume":"93","author":"Wang","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib43","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/j.1524-4725.2012.02570.x","article-title":"Clinical value of paraffin sections in association with Mohs micrographic surgery for nonmelanoma skin cancers","volume":"38","author":"Ebede","year":"2012","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2025.11.043_bib44","series-title":"Position Statement on Appropriate Uses of Paraffin Sections in Association with Mohs Micrographic Surgery","year":"2014"},{"key":"10.1016\/j.jaad.2025.11.043_bib45","first-page":"262","article-title":"Dual immunostaining with SOX10 and AE1\/AE3 to confirm perineural invasion on mohs sections","volume":"18","author":"Donaldson","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib46","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1002\/hed.26767","article-title":"Adjuvant therapy for high-risk cutaneous squamous cell carcinoma: 10-year review","volume":"43","author":"Newman","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/j.jaad.2025.11.043_bib47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jaad.2022.03.044","article-title":"Adjuvant radiation following clear margin resection of high T-stage cutaneous squamous cell carcinoma halves the risk of local and locoregional recurrence: a dual-center retrospective study","volume":"87","author":"Ruiz","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib48","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jamaoto.2018.3650","article-title":"Association of adjuvant radiation therapy with survival in patients with advanced cutaneous squamous cell carcinoma of the head and neck","volume":"145","author":"Harris","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"8","key":"10.1016\/j.jaad.2025.11.043_bib50","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1056\/NEJMoa2502449","article-title":"Adjuvant cemiplimab or placebo in high-risk cutaneous squamous-cell carcinoma","volume":"393","author":"Rischin","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2025.11.043_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jamadermatol.2013.6675","article-title":"Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system","volume":"150","author":"Schmitt","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib52","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/1346-8138.14342","article-title":"Systematic review of the prevalence of nodal metastases and the prognostic utility of sentinel lymph node biopsy in cutaneous squamous cell carcinoma","volume":"45","author":"Tejera-Vaquerizo","year":"2018","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib53","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/DSS.0000000000003085","article-title":"Sentinel lymph node biopsy in high-risk cutaneous squamous cell carcinoma: analysis of a large size retrospective series","volume":"47","author":"Tremblay-Abel","year":"2021","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2025.11.043_bib54","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/DSS.0000000000003304","article-title":"Outcomes of sentinel lymph node biopsy for primary cutaneous squamous cell carcinoma of the head and neck","volume":"48","author":"Pride","year":"2022","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2025.11.043_bib55","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2340\/00015555-2942","article-title":"Sentinel lymph node biopsy in cutaneous squamous cell carcinoma series of 37 cases and systematic review of the literature","volume":"98","author":"Lhote","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2025.11.043_bib56","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bjps.2021.08.041","article-title":"Sentinel lymph node biopsy in high-risk cutaneous squamous cell carcinoma of the head and neck","volume":"75","author":"Ilmonen","year":"2022","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.jaad.2025.11.043_bib57","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/jamaoto.2024.0259","article-title":"Neoadjuvant-Intent immunotherapy in advanced, resectable cutaneous squamous cell carcinoma","volume":"150","author":"Kim","year":"2024","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaad.2025.11.043_bib58","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/COC.0000000000000088","article-title":"Systemic therapy in advanced cutaneous squamous cell carcinoma (CSCC): the roswell park experience and a review of the literature","volume":"39","author":"Jarkowski","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jaad.2025.11.043_bib59","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1200\/JCO.2010.34.1735","article-title":"Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin","volume":"29","author":"Maubec","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2025.11.043_bib60","article-title":"Immunotherapy for cutaneous squamous cell carcinoma: results and perspectives","volume":"11","author":"Alberti","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.jaad.2025.11.043_bib61","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1470-2045(19)30728-4","article-title":"Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial","volume":"21","author":"Migden","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2025.11.043_bib62","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1200\/JCO.19.03054","article-title":"Pembrolizumab monotherapy for recurrent or metastatic cutaneous squamous cell carcinoma: a single-arm phase II trial (KEYNOTE-629)","volume":"38","author":"Grob","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2025.11.043_bib63","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1200\/JCO.19.03357","article-title":"Phase II study of pembrolizumab as first-line, single-drug therapy for patients with unresectable cutaneous squamous cell carcinomas","volume":"38","author":"Maubec","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2025.11.043_bib64","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1634\/theoncologist.2019-0659","article-title":"The safety and efficacy of checkpoint inhibitors in transplant recipients: a case series and systematic review of literature","volume":"25","author":"Kumar","year":"2020","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.jaad.2025.11.043_bib65","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000908","article-title":"Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients","volume":"8","author":"Trager","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jaad.2025.11.043_bib66","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jaad.2019.07.005","article-title":"Immune checkpoint inhibitor therapy in solid organ transplant recipients: a patient-centered systematic review","volume":"82","author":"Fisher","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100844","article-title":"Vismodegib in neoadjuvant treatment of locally advanced basal cell carcinoma: first results of a multicenter, open-label, phase 2 trial (VISMONEO study): Neoadjuvant vismodegib in locally advanced basal cell carcinoma","volume":"35","author":"Bertrand","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jaad.2025.11.043_bib68","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jamadermatol.2022.0001","article-title":"Implications of satellitosis or In-transit metastasis in cutaneous squamous cell carcinoma: a prognostic omission in cancer staging systems","volume":"158","author":"Smile","year":"2022","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib69","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1200\/JCO.2017.77.0941","article-title":"Postoperative concurrent chemoradiotherapy versus postoperative radiotherapy in high-risk cutaneous squamous cell carcinoma of the head and neck: the randomized phase III TROG 05.01 trial","volume":"36","author":"Porceddu","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2025.11.043_bib70","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jaad.2023.02.048","article-title":"Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: a multicentric cohort study","volume":"89","author":"Marti-Marti","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib71","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.ijrobp.2024.05.022","article-title":"Association of a 40-Gene expression profile with risk of metastatic disease progression of cutaneous squamous cell carcinoma and specification of benefit of adjuvant radiation therapy","volume":"120","author":"Arron","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jaad.2025.11.043_bib72","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaad.2020.04.088","article-title":"Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma","volume":"84","author":"Wysong","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib73","doi-asserted-by":"crossref","first-page":"833","DOI":"10.2217\/fon-2021-1277","article-title":"Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile test","volume":"18","author":"Ibrahim","year":"2022","journal-title":"Future Oncol"},{"key":"10.1016\/j.jaad.2025.11.043_bib74","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1080\/14796694.2024.2390820","article-title":"Predicting adjuvant radiation therapy benefit in cutaneous squamous cell carcinoma with the 40-gene expression profile","volume":"20","author":"Ruiz","year":"2024","journal-title":"Future Oncol"},{"key":"10.1016\/j.jaad.2025.11.043_bib75","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1001\/jama.1992.03480240067036","article-title":"Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin cancer prevention study group","volume":"267","author":"Karagas","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2025.11.043_bib76","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.ejca.2013.03.010","article-title":"Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis","volume":"49","author":"Flohil","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jaad.2025.11.043_bib77","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archderm.136.12.1524","article-title":"Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis","volume":"136","author":"Marcil","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib78","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1001\/jamadermatol.2013.9313","article-title":"Clinical skin examination outcomes after a video-based behavioral intervention: analysis from a randomized clinical trial","volume":"150","author":"Janda","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib79","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaad.2016.02.1236","article-title":"Sunburn and sun-protective behaviors among adults with and without previous nonmelanoma skin cancer (NMSC): a population-based study","volume":"75","author":"Fischer","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib80","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.1995.13.8.1933","article-title":"Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study","volume":"13","author":"Bavinck","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2025.11.043_bib81","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1056\/NEJM198806233182501","article-title":"Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin","volume":"318","author":"Kraemer","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2025.11.043_bib82","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1067\/S0190-9622(03)01831-0","article-title":"Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin","volume":"49","author":"de S\u00e9vaux","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib83","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1440-0960.2002.00613.x","article-title":"Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients","volume":"43","author":"George","year":"2002","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib84","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamadermatol.2020.2327","article-title":"Evaluation of the use of capecitabine for the treatment and prevention of actinic keratoses, squamous cell carcinoma, and basal cell carcinoma: a systematic review","volume":"156","author":"Schauder","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib85","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/jid.2011.483","article-title":"Tretinoin and the prevention of keratinocyte carcinoma (basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial","volume":"132","author":"Weinstock","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib86","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1158\/1940-6207.CAPR-13-0305","article-title":"Tazarotene: randomized, double-blind, vehicle-controlled, and open-label concurrent trials for basal cell carcinoma prevention and therapy in patients with basal cell nevus syndrome","volume":"7","author":"Tang","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.jaad.2025.11.043_bib87","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention","volume":"373","author":"Chen","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2025.11.043_bib88","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMoa2203086","article-title":"Nicotinamide for skin-cancer chemoprevention in transplant recipients","volume":"388","author":"Allen","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2025.11.043_bib89","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"Sirolimus and secondary skin-cancer prevention in kidney transplantation","volume":"367","author":"Euvrard","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2025.11.043_bib90","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/j.1600-6143.2009.02997.x","article-title":"Switch to a sirolimus-based immunosuppression in long-term renal transplant recipients: reduced rate of (pre-)malignancies and nonmelanoma skin cancer in a prospective, randomized, assessor-blinded, controlled clinical trial","volume":"10","author":"Salgo","year":"2010","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jaad.2025.11.043_bib91","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1200\/JCO.2012.45.6376","article-title":"Two-year randomized controlled prospective trial converting treatment of stable renal transplant recipients with cutaneous invasive squamous cell carcinomas to sirolimus","volume":"31","author":"Hoogendijk-van den Akker","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2025.11.043_bib92","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1600-6143.2012.04004.x","article-title":"Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer","volume":"12","author":"Campbell","year":"2012","journal-title":"Am J Transpl"},{"key":"10.1016\/j.jaad.2025.11.043_bib93","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1097\/TXD.0000000000000579","article-title":"Open-Label, randomized study of transition from tacrolimus to sirolimus immunosuppression in renal allograft recipients","volume":"2","author":"Tedesco-Silva","year":"2016","journal-title":"Transpl Direct"},{"key":"10.1016\/j.jaad.2025.11.043_bib94","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.kint.2016.11.008","article-title":"The risk of cancer in kidney transplant recipients may be reduced in those maintained on everolimus and reduced cyclosporine","volume":"91","author":"Lim","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.jaad.2025.11.043_bib95","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/dsu.12049","article-title":"Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients","volume":"39","author":"Endrizzi","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2025.11.043_bib96","first-page":"813","article-title":"Sirolimus and mTOR inhibitors: a review of side effects and specific management in solid organ transplantation","volume":"42","author":"Nguyen","year":"2019","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaad.2025.11.043_bib97","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jamadermatol.2020.2571","article-title":"Association of age, sex, race, and geographic region with variation of the ratio of basal cell to cutaneous squamous cell carcinomas in the United States","volume":"156","author":"Lukowiak","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2025.11.043_bib98","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMoa2209813","article-title":"Neoadjuvant cemiplimab for stage II to IV cutaneous squamous-cell carcinoma","volume":"387","author":"Gross","year":"2022","journal-title":"N Engl J Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225032463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962225032463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T05:36:27Z","timestamp":1771392987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962225032463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0190962225032463"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.11.043","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of cutaneous squamous cell carcinoma: A literature review and update","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.11.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}